Skip to main content
. Author manuscript; available in PMC: 2022 Feb 8.
Published in final edited form as: Am J Ophthalmol. 2021 Jun 29;234:188–198. doi: 10.1016/j.ajo.2021.06.021

TABLE 5.

Timing and Location of Disc Hemorrhage Occurrence and Glaucoma Progression in the Open-Angle Glaucoma Study Patients With Disc Hemorrhage

Patient
Number
Glaucoma
Severity
Follow-up Duration
(mo)
DH Occurrence
(mo)
DH Location DP Progression
(mo)
HVF Progression
(mo)
RNFL Progression
(mo)
MDB Progression
(mo)
MDB Progression
Location
Glaucoma Therapy
Escalation
1 Mild 71 44 IT 10 S
2 Mild 64 41, 64 IT, ST 41 G/S/I
3 Moderate 47 31 SN 6, 31 G, S
4 Moderate 66 66 ST 54 54 G/S
5 Mild 68 46 IT/I 10 S
6 Severe 42 0, 42 IT, IT 14 Yes (after 2nd DH)
7 Mild 69 56 I/ST 26 13
8 Moderate 56 30, 56 I, I 56 56 14 14 G/S/I
9 Mild 76 30 IT 40 30 15, 30, 40 I, G, S
10 Mild 44 11 N 19, 44 I, G/S
11 Moderate 89 0 IT 55 55 25 25, 89 G/I, S
12 Mild 72 57 I 13 G/S
13 Moderate 62 0 IT 41 21 8 G/S
14 Moderate 56 24, 36, 48 IT, IT, IT 36 24 I
15 Mild 70 36 IN 36 53 18 18, 30 G/S, I
16 Moderate 65 12, 41, 53 ST, ST, T 12 S
17 Mild 49 49 N 21 21 G/S
18 Mild 46 34 N 34 18 18 G/S/I Yes
19 Moderate 53 36, 53 ST, ST 36 11 36 11 G/S/I

DH = disc hemorrhage; DP = disc photo; G = global; HVF = Humphrey visual field; I = inferior; IN = inferonasal; IT = inferotemporal; MDB = minimum distance band; N = nasal; RNFL = retinal nerve fiber layer; S = superior; SN = superonasal; ST = superotemporal; T = temporal.

Time of DH occurrence and glaucoma progression is expressed as months from baseline visit. Events noted during the same visit are separated by a forward slash; events noted on subsequent visits are separated by a comma. Glaucoma therapy escalation refers to intensification of glaucoma therapy within 1 y after each documented instance of DH.